Ilan Volovitz, Ph.D.

Affiliations: 
2006 Weizmann Institute of Science, Rehovot, Israel 
Area:
Immunology
Google:
"Ilan Volovitz"

Parents

Sign in to add mentor
Lea Eisenbach grad student 2006 Weizmann Institute
 (Manipulating immunity to self in autoimmunity and tumor immunotherapy.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Simchony H, Diamant D, Ram Z, et al. (2019) Evaluation of the Compatibility of Electric Tumor Treating Fields with Key Anti-tumoral T-Cell Functions. The Israel Medical Association Journal : Imaj. 21: 503
Volovitz I, Shapira N, Ezer H, et al. (2016) A non-aggressive, highly efficient, enzymatic method for dissociation of human brain-tumors and brain-tissues to viable single-cells. Bmc Neuroscience. 17: 30
Volovitz I, Melzer S, Amar S, et al. (2016) Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools. International Reviews of Immunology. 35: 116-35
Volovitz I, Marmor Y, Azulay M, et al. (2011) Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 5452-62
Kovjazin R, Volovitz I, Kundel Y, et al. (2011) ImMucin: a novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors. Vaccine. 29: 4676-86
Kovjazin R, Volovitz I, Daon Y, et al. (2011) Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development. Molecular Immunology. 48: 1009-18
Volovitz I, Marmor Y, Mor F, et al. (2010) T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells. Journal of Autoimmunity. 35: 135-44
Volovitz I, Mor F, Machlenkin A, et al. (2009) T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Immunology. 128: 92-102
Goldberger O, Volovitz I, Machlenkin A, et al. (2008) Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Research. 68: 3450-7
Machlenkin A, Azriel-Rosenfeld R, Volovitz I, et al. (2007) Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology, Immunotherapy : Cii. 56: 217-26
See more...